Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort Yousef Almahanna; Francisco Idalsoaga; Luis Antonio Díaz; Ahmed Almohsen; Yi Nong Song; Amani Bajunayd; Rokhsana Mortuza; Jeemin Kim; Adrienne Abaya; Mohammad Qasim Khan; Juan Pablo Arab;

Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;